Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C

K. Rajender Reddy, Teresa L. Wright, Paul J. Pockros, Mitchell Shiffman, Gregory Everson, Robert Reindollar, Michael W. Fried, Preston P. Purdum, Donald Jensen, Coleman Smith, William M. Lee, Thomas D. Boyer, Amy Lin, Simon Pedder, Jean DePamphilis

Research output: Contribution to journalArticlepeer-review

347 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C'. Together they form a unique fingerprint.

Medicine & Life Sciences